Structure

Physi-Chem Properties

Molecular Weight:  464.29
Volume:  515.836
LogP:  7.89
LogD:  4.893
LogS:  -2.3
# Rotatable Bonds:  8
TPSA:  69.92
# H-Bond Aceptor:  4
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.366
Synthetic Accessibility Score:  3.428
Fsp3:  0.467
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.17
MDCK Permeability:  1.6393767509725876e-05
Pgp-inhibitor:  0.961
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.045
20% Bioavailability (F20%):  0.998
30% Bioavailability (F30%):  0.959

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.025
Plasma Protein Binding (PPB):  100.51758575439453%
Volume Distribution (VD):  4.657
Pgp-substrate:  0.9723663330078125%

ADMET: Metabolism

CYP1A2-inhibitor:  0.414
CYP1A2-substrate:  0.421
CYP2C19-inhibitor:  0.715
CYP2C19-substrate:  0.07
CYP2C9-inhibitor:  0.334
CYP2C9-substrate:  0.961
CYP2D6-inhibitor:  0.826
CYP2D6-substrate:  0.906
CYP3A4-inhibitor:  0.386
CYP3A4-substrate:  0.211

ADMET: Excretion

Clearance (CL):  4.612
Half-life (T1/2):  0.143

ADMET: Toxicity

hERG Blockers:  0.149
Human Hepatotoxicity (H-HT):  0.372
Drug-inuced Liver Injury (DILI):  0.012
AMES Toxicity:  0.043
Rat Oral Acute Toxicity:  0.135
Maximum Recommended Daily Dose:  0.876
Skin Sensitization:  0.938
Carcinogencity:  0.035
Eye Corrosion:  0.003
Eye Irritation:  0.859
Respiratory Toxicity:  0.521

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC198038

Natural Product ID:  NPC198038
Common Name*:   Kazinol D
IUPAC Name:   4-[3-[8-hydroxy-2,2-dimethyl-5-(3-methylbut-2-enyl)-3,4-dihydrochromen-6-yl]propyl]-6-(2-methylbut-3-en-2-yl)benzene-1,3-diol
Synonyms:   Kazinol D
Standard InCHIKey:  ADFDRHICFIZUNK-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C30H40O4/c1-8-29(4,5)24-16-21(25(31)18-26(24)32)11-9-10-20-17-27(33)28-23(14-15-30(6,7)34-28)22(20)13-12-19(2)3/h8,12,16-18,31-33H,1,9-11,13-15H2,2-7H3
SMILES:  C=CC(c1cc(CCCc2cc(O)c3c(c2CC=C(C)C)CCC(O3)(C)C)c(cc1O)O)(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL454305
PubChem CID:   21637680
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0003522] 2,2-dimethyl-1-benzopyrans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO16111 Broussonetia kazinoki Species Moraceae Eukaryota Leaves n.a. n.a. PMID[11575957]
NPO16111 Broussonetia kazinoki Species Moraceae Eukaryota n.a. n.a. n.a. PMID[19046886]
NPO16111 Broussonetia kazinoki Species Moraceae Eukaryota n.a. n.a. n.a. PMID[20493686]
NPO16111 Broussonetia kazinoki Species Moraceae Eukaryota n.a. n.a. n.a. PMID[9917310]
NPO16111 Broussonetia kazinoki Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16111 Broussonetia kazinoki Species Moraceae Eukaryota n.a. n.a. n.a. Database[TM-MC]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT43 Individual Protein Tyrosinase Agaricus bisporus IC50 = 164700.0 nM PMID[528589]
NPT43 Individual Protein Tyrosinase Agaricus bisporus IC50 > 200000.0 nM PMID[528589]
NPT2428 Cell Line HT-3 Homo sapiens ED50 = 3.6 ug ml-1 PMID[528590]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. ED50 = 3.3 ug ml-1 PMID[528590]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. ED50 = 7.0 ug ml-1 PMID[528590]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC198038 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.985 High Similarity NPC234568
0.9489 High Similarity NPC474104
0.9429 High Similarity NPC473876
0.9343 High Similarity NPC35216
0.9281 High Similarity NPC473845
0.9281 High Similarity NPC50250
0.9281 High Similarity NPC469795
0.9248 High Similarity NPC469907
0.9203 High Similarity NPC71046
0.9197 High Similarity NPC260741
0.9197 High Similarity NPC32630
0.9197 High Similarity NPC70682
0.9161 High Similarity NPC195561
0.9149 High Similarity NPC233980
0.9143 High Similarity NPC473108
0.9137 High Similarity NPC59841
0.9137 High Similarity NPC475891
0.9137 High Similarity NPC2613
0.9137 High Similarity NPC204347
0.9124 High Similarity NPC35550
0.9104 High Similarity NPC15543
0.9097 High Similarity NPC2745
0.9085 High Similarity NPC474397
0.9065 High Similarity NPC265075
0.9051 High Similarity NPC265433
0.9051 High Similarity NPC162659
0.9051 High Similarity NPC227503
0.9051 High Similarity NPC270456
0.9051 High Similarity NPC474639
0.9051 High Similarity NPC230734
0.9051 High Similarity NPC234952
0.9051 High Similarity NPC248727
0.9044 High Similarity NPC317380
0.9037 High Similarity NPC127624
0.9037 High Similarity NPC86655
0.9037 High Similarity NPC202762
0.9034 High Similarity NPC157783
0.903 High Similarity NPC126836
0.9028 High Similarity NPC158784
0.9021 High Similarity NPC212142
0.8993 High Similarity NPC259519
0.8986 High Similarity NPC56329
0.8986 High Similarity NPC242715
0.8978 High Similarity NPC112939
0.8978 High Similarity NPC313081
0.8978 High Similarity NPC473413
0.8978 High Similarity NPC474206
0.8978 High Similarity NPC151224
0.8978 High Similarity NPC69029
0.8978 High Similarity NPC158142
0.8978 High Similarity NPC94750
0.8978 High Similarity NPC121812
0.8978 High Similarity NPC200557
0.8978 High Similarity NPC108198
0.8978 High Similarity NPC112246
0.8978 High Similarity NPC241241
0.8978 High Similarity NPC294884
0.8978 High Similarity NPC10314
0.8978 High Similarity NPC470356
0.8966 High Similarity NPC302915
0.8947 High Similarity NPC252131
0.8947 High Similarity NPC470699
0.8921 High Similarity NPC127218
0.8921 High Similarity NPC19869
0.8921 High Similarity NPC275061
0.8921 High Similarity NPC319647
0.8921 High Similarity NPC132804
0.8921 High Similarity NPC25966
0.8921 High Similarity NPC220344
0.8921 High Similarity NPC243996
0.8921 High Similarity NPC245207
0.8913 High Similarity NPC202846
0.8913 High Similarity NPC470802
0.8913 High Similarity NPC302701
0.8913 High Similarity NPC269091
0.8913 High Similarity NPC306441
0.8913 High Similarity NPC30632
0.8913 High Similarity NPC16435
0.8913 High Similarity NPC143139
0.8905 High Similarity NPC209199
0.8905 High Similarity NPC125649
0.8904 High Similarity NPC160196
0.8904 High Similarity NPC325860
0.8881 High Similarity NPC226331
0.8881 High Similarity NPC46274
0.8881 High Similarity NPC211758
0.8881 High Similarity NPC28765
0.8881 High Similarity NPC87794
0.8873 High Similarity NPC280092
0.8873 High Similarity NPC93323
0.8873 High Similarity NPC63879
0.8873 High Similarity NPC45257
0.8873 High Similarity NPC12641
0.8872 High Similarity NPC181361
0.8865 High Similarity NPC323126
0.8857 High Similarity NPC309124
0.8857 High Similarity NPC12668
0.8857 High Similarity NPC308768
0.8857 High Similarity NPC184797
0.8849 High Similarity NPC230919
0.8849 High Similarity NPC276490
0.8849 High Similarity NPC266453
0.8849 High Similarity NPC200935
0.8849 High Similarity NPC22902
0.8849 High Similarity NPC103976
0.8849 High Similarity NPC211549
0.8849 High Similarity NPC326797
0.8849 High Similarity NPC102904
0.8849 High Similarity NPC107551
0.8849 High Similarity NPC474282
0.8849 High Similarity NPC176051
0.8841 High Similarity NPC234333
0.8841 High Similarity NPC47398
0.8841 High Similarity NPC164787
0.8841 High Similarity NPC260898
0.8841 High Similarity NPC61946
0.8832 High Similarity NPC11060
0.8832 High Similarity NPC229442
0.8832 High Similarity NPC36661
0.8832 High Similarity NPC475840
0.8832 High Similarity NPC32778
0.8832 High Similarity NPC168059
0.8819 High Similarity NPC16269
0.8819 High Similarity NPC21776
0.8811 High Similarity NPC90645
0.8806 High Similarity NPC74817
0.8806 High Similarity NPC236791
0.8806 High Similarity NPC124452
0.8806 High Similarity NPC324112
0.8806 High Similarity NPC282000
0.8806 High Similarity NPC159968
0.8806 High Similarity NPC169474
0.8806 High Similarity NPC5447
0.8806 High Similarity NPC293054
0.8806 High Similarity NPC246620
0.8806 High Similarity NPC210355
0.8806 High Similarity NPC250432
0.8806 High Similarity NPC82679
0.8803 High Similarity NPC85264
0.8803 High Similarity NPC47633
0.8803 High Similarity NPC102044
0.8794 High Similarity NPC263261
0.8794 High Similarity NPC87725
0.8794 High Similarity NPC471389
0.8788 High Similarity NPC53567
0.8786 High Similarity NPC236306
0.8786 High Similarity NPC243759
0.8786 High Similarity NPC79622
0.8786 High Similarity NPC212942
0.8786 High Similarity NPC105847
0.8786 High Similarity NPC473739
0.8786 High Similarity NPC184613
0.8786 High Similarity NPC55947
0.8786 High Similarity NPC29868
0.8786 High Similarity NPC232164
0.8786 High Similarity NPC218131
0.8784 High Similarity NPC80918
0.8784 High Similarity NPC188578
0.8777 High Similarity NPC173660
0.8768 High Similarity NPC160697
0.8768 High Similarity NPC66840
0.8768 High Similarity NPC478085
0.8768 High Similarity NPC256307
0.8759 High Similarity NPC14224
0.8759 High Similarity NPC161958
0.875 High Similarity NPC260397
0.875 High Similarity NPC474481
0.875 High Similarity NPC91291
0.8741 High Similarity NPC277951
0.8741 High Similarity NPC317237
0.8741 High Similarity NPC154866
0.8741 High Similarity NPC44530
0.8732 High Similarity NPC183709
0.8732 High Similarity NPC107161
0.8732 High Similarity NPC175838
0.8731 High Similarity NPC18924
0.8731 High Similarity NPC44748
0.8731 High Similarity NPC214406
0.8731 High Similarity NPC78974
0.8731 High Similarity NPC223136
0.8731 High Similarity NPC103823
0.8731 High Similarity NPC28730
0.8723 High Similarity NPC472092
0.8723 High Similarity NPC472090
0.8723 High Similarity NPC472091
0.8723 High Similarity NPC109240
0.8722 High Similarity NPC122792
0.8722 High Similarity NPC228972
0.8714 High Similarity NPC94994
0.8714 High Similarity NPC266006
0.8714 High Similarity NPC151656
0.8705 High Similarity NPC180602
0.8705 High Similarity NPC55239
0.8705 High Similarity NPC214853
0.8705 High Similarity NPC327382
0.8705 High Similarity NPC256262
0.8705 High Similarity NPC195022
0.8705 High Similarity NPC240279
0.8699 High Similarity NPC476969
0.8696 High Similarity NPC263064

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC198038 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8881 High Similarity NPD1529 Clinical (unspecified phase)
0.8806 High Similarity NPD1530 Clinical (unspecified phase)
0.8676 High Similarity NPD4625 Phase 3
0.8623 High Similarity NPD1612 Clinical (unspecified phase)
0.8623 High Similarity NPD1613 Approved
0.8406 Intermediate Similarity NPD3027 Phase 3
0.8345 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8214 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.8201 Intermediate Similarity NPD4908 Phase 1
0.8102 Intermediate Similarity NPD4749 Approved
0.8088 Intermediate Similarity NPD1610 Phase 2
0.7972 Intermediate Similarity NPD4060 Phase 1
0.7945 Intermediate Similarity NPD6099 Approved
0.7945 Intermediate Similarity NPD6100 Approved
0.7935 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7871 Intermediate Similarity NPD1934 Approved
0.7847 Intermediate Similarity NPD3620 Phase 2
0.7847 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7794 Intermediate Similarity NPD1548 Phase 1
0.7786 Intermediate Similarity NPD6696 Suspended
0.7786 Intermediate Similarity NPD8651 Approved
0.7785 Intermediate Similarity NPD6674 Discontinued
0.7785 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7762 Intermediate Similarity NPD7095 Approved
0.7746 Intermediate Similarity NPD3018 Phase 2
0.7733 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7714 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7707 Intermediate Similarity NPD2801 Approved
0.7704 Intermediate Similarity NPD6671 Approved
0.7687 Intermediate Similarity NPD5283 Phase 1
0.7676 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7669 Intermediate Similarity NPD228 Approved
0.7625 Intermediate Similarity NPD6234 Discontinued
0.7622 Intermediate Similarity NPD2861 Phase 2
0.7595 Intermediate Similarity NPD1465 Phase 2
0.7589 Intermediate Similarity NPD2983 Phase 2
0.7589 Intermediate Similarity NPD2982 Phase 2
0.7582 Intermediate Similarity NPD1511 Approved
0.7576 Intermediate Similarity NPD5844 Phase 1
0.7574 Intermediate Similarity NPD7157 Approved
0.7551 Intermediate Similarity NPD5735 Approved
0.7531 Intermediate Similarity NPD7199 Phase 2
0.7519 Intermediate Similarity NPD3022 Approved
0.7519 Intermediate Similarity NPD3021 Approved
0.7518 Intermediate Similarity NPD2981 Phase 2
0.7515 Intermediate Similarity NPD8053 Approved
0.7515 Intermediate Similarity NPD8054 Approved
0.7515 Intermediate Similarity NPD7228 Approved
0.75 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3882 Suspended
0.75 Intermediate Similarity NPD1653 Approved
0.75 Intermediate Similarity NPD6166 Phase 2
0.75 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD6232 Discontinued
0.7484 Intermediate Similarity NPD1512 Approved
0.7484 Intermediate Similarity NPD7819 Suspended
0.7483 Intermediate Similarity NPD1558 Phase 1
0.7465 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7455 Intermediate Similarity NPD7473 Discontinued
0.7439 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7425 Intermediate Similarity NPD7074 Phase 3
0.7421 Intermediate Similarity NPD37 Approved
0.7394 Intermediate Similarity NPD2489 Approved
0.7394 Intermediate Similarity NPD27 Approved
0.7391 Intermediate Similarity NPD4966 Approved
0.7391 Intermediate Similarity NPD7340 Approved
0.7391 Intermediate Similarity NPD4965 Approved
0.7391 Intermediate Similarity NPD4967 Phase 2
0.7386 Intermediate Similarity NPD3750 Approved
0.7384 Intermediate Similarity NPD7906 Approved
0.7383 Intermediate Similarity NPD4097 Suspended
0.7365 Intermediate Similarity NPD7054 Approved
0.7358 Intermediate Similarity NPD6072 Discontinued
0.7353 Intermediate Similarity NPD7311 Approved
0.7353 Intermediate Similarity NPD7313 Approved
0.7353 Intermediate Similarity NPD7312 Approved
0.7353 Intermediate Similarity NPD7310 Approved
0.7347 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7346 Intermediate Similarity NPD7075 Discontinued
0.7343 Intermediate Similarity NPD5327 Phase 3
0.7333 Intermediate Similarity NPD4536 Approved
0.7333 Intermediate Similarity NPD4538 Approved
0.7333 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7324 Intermediate Similarity NPD422 Phase 1
0.7321 Intermediate Similarity NPD7472 Approved
0.7315 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7315 Intermediate Similarity NPD5124 Phase 1
0.731 Intermediate Similarity NPD7309 Approved
0.7308 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD7447 Phase 1
0.7303 Intermediate Similarity NPD5763 Approved
0.7303 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD5762 Approved
0.7299 Intermediate Similarity NPD1398 Phase 1
0.729 Intermediate Similarity NPD7124 Phase 2
0.7267 Intermediate Similarity NPD6353 Approved
0.7267 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD5494 Approved
0.7251 Intermediate Similarity NPD4577 Approved
0.7251 Intermediate Similarity NPD4578 Approved
0.7233 Intermediate Similarity NPD4005 Discontinued
0.7229 Intermediate Similarity NPD2970 Approved
0.7229 Intermediate Similarity NPD2969 Approved
0.7226 Intermediate Similarity NPD7843 Approved
0.7225 Intermediate Similarity NPD4663 Approved
0.7222 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD3817 Phase 2
0.7203 Intermediate Similarity NPD3705 Approved
0.7202 Intermediate Similarity NPD3818 Discontinued
0.7197 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7192 Intermediate Similarity NPD4624 Approved
0.719 Intermediate Similarity NPD3540 Phase 1
0.7188 Intermediate Similarity NPD4380 Phase 2
0.7185 Intermediate Similarity NPD2684 Approved
0.7183 Intermediate Similarity NPD4626 Approved
0.7171 Intermediate Similarity NPD5588 Approved
0.7171 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7171 Intermediate Similarity NPD5960 Phase 3
0.7171 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD3051 Approved
0.7169 Intermediate Similarity NPD6071 Discontinued
0.7161 Intermediate Similarity NPD6331 Phase 2
0.7161 Intermediate Similarity NPD3892 Phase 2
0.716 Intermediate Similarity NPD5929 Approved
0.7135 Intermediate Similarity NPD7251 Discontinued
0.7134 Intermediate Similarity NPD7213 Phase 3
0.7134 Intermediate Similarity NPD7041 Phase 2
0.7134 Intermediate Similarity NPD7831 Phase 2
0.7134 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD7212 Phase 2
0.7134 Intermediate Similarity NPD7040 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD7833 Phase 2
0.7133 Intermediate Similarity NPD4140 Approved
0.7132 Intermediate Similarity NPD4750 Phase 3
0.7124 Intermediate Similarity NPD3539 Phase 1
0.7121 Intermediate Similarity NPD940 Approved
0.7121 Intermediate Similarity NPD846 Approved
0.7117 Intermediate Similarity NPD2560 Approved
0.7117 Intermediate Similarity NPD2563 Approved
0.7115 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD6959 Discontinued
0.7105 Intermediate Similarity NPD6111 Discontinued
0.7101 Intermediate Similarity NPD8099 Discontinued
0.7101 Intermediate Similarity NPD8251 Approved
0.7101 Intermediate Similarity NPD8252 Approved
0.7093 Intermediate Similarity NPD7808 Phase 3
0.7093 Intermediate Similarity NPD7549 Discontinued
0.7086 Intermediate Similarity NPD6355 Discontinued
0.7086 Intermediate Similarity NPD3657 Discovery
0.7083 Intermediate Similarity NPD1611 Approved
0.7083 Intermediate Similarity NPD1091 Approved
0.7081 Intermediate Similarity NPD4675 Approved
0.7081 Intermediate Similarity NPD4678 Approved
0.7078 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7078 Intermediate Similarity NPD7266 Discontinued
0.7078 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7076 Intermediate Similarity NPD6797 Phase 2
0.7075 Intermediate Similarity NPD6584 Phase 3
0.7073 Intermediate Similarity NPD7768 Phase 2
0.707 Intermediate Similarity NPD5058 Phase 3
0.7066 Intermediate Similarity NPD7229 Phase 3
0.7059 Intermediate Similarity NPD8156 Discontinued
0.7059 Intermediate Similarity NPD3748 Approved
0.7051 Intermediate Similarity NPD7466 Approved
0.7051 Intermediate Similarity NPD6658 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD4110 Phase 3
0.7045 Intermediate Similarity NPD1242 Phase 1
0.7037 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7035 Intermediate Similarity NPD7240 Approved
0.7032 Intermediate Similarity NPD2424 Discontinued
0.7032 Intermediate Similarity NPD1549 Phase 2
0.703 Intermediate Similarity NPD4055 Discovery
0.703 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7007 Intermediate Similarity NPD2797 Approved
0.7007 Intermediate Similarity NPD3094 Phase 2
0.7006 Intermediate Similarity NPD8127 Discontinued
0.7006 Intermediate Similarity NPD2677 Approved
0.7 Intermediate Similarity NPD5111 Phase 2
0.7 Intermediate Similarity NPD6798 Discontinued
0.7 Intermediate Similarity NPD5110 Phase 2
0.7 Intermediate Similarity NPD5109 Approved
0.6994 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6993 Remote Similarity NPD5691 Approved
0.6993 Remote Similarity NPD1357 Approved
0.6987 Remote Similarity NPD5177 Phase 3
0.6987 Remote Similarity NPD1652 Phase 2
0.6985 Remote Similarity NPD290 Approved
0.6981 Remote Similarity NPD1754 Clinical (unspecified phase)
0.6981 Remote Similarity NPD7004 Clinical (unspecified phase)
0.698 Remote Similarity NPD5752 Clinical (unspecified phase)
0.6978 Remote Similarity NPD5535 Approved
0.6978 Remote Similarity NPD7635 Approved
0.6978 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6977 Remote Similarity NPD7993 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data